London, 11-13 Nov 2019


3 day Masterclass

Valuation of Pharmaceutical Licences

KEY VALUATION TECHNIQUES • PRACTICAL EXERCISES • HANDS-ON GUIDANCE


book before 23rd August and save £635

LEARN THE FUNDAMENTALS OF PHARMA PRODUCT AND LICENSE VALUATION

This course aims to fill this gap, and starts with a grounding in the fundamental concepts of valuation and gives delegates hands-on experience to create their own valuation models within the first couple of hours

Learn bulb

develop new skills

Understand the techniques for valuing different types of companies and which valuation techniques to apply in differing circumstances

Learn bulb

get practical

Build your own valuation models for both products and companies

Learn bulb

learn from the best

Learn from the experiences of a course leader who regularly values pharmaceutical products and companies internationally

APPLY BEST PRACTICE VALUATION TECHNIQUES IMMEDIATELY INTO YOUR OWN PRACTICE

Pharmaceutical professionals that do not have a finance background often struggle to understand the approaches used in the valuation of products for licensing and acquisition, and lack the skills to undertake their own assessments.  

 

book today saving £635

In just 3 days you will:

  • Learn fundamental valuation concepts, including Discounted Cash Flow (DCF), Net Present Value (NPV) and the use of comparables to benchmark license or acquisition deals.
  • Acquire the skills to create complex valuation models, taking into account the risks inherent with pharmaceutical products including development risk, patent expiry and market environment.
  • Understand what types of intellectual property can be licensed, and how to structure a licensing deal for a pharmaceutical product.
  • Learn how to model alternative deal structures and to undertake sophisticated scenario analysis.
  • Gain an understanding of the fundamental drivers of licenses and acquisitions and the licensing and acquisition process, including the application of different screening and selection tools.

Meet your instructor

Dr Simon Bennett is an independent consultant and registered Growth Coach with over twenty years of industry experience. He mentors and advises early-stage businesses and management teams, and has senior management experience from start-up through to IPO and trade sale, with responsibilities covering all aspects of business and corporate development. His experience spans bio-pharma, biotech, genomics and specialty pharma, as well as web 2.0.
Simon currently manages a portfolio of around ten companies and is a board director of MitoDys Therapeutics and Xobaderm, until its recent acquisition by FTSE 100 Informa plc, was a non-executive director of colwiz. He is currently advising and providing business development support to several companies, including Bristol-Myers Squibb, Oxford Pharmacience, Beijing Tide Pharma and Xobaderm. He has been involved in over 70 commercial deals globally, with both Big Pharma and biotech companies. Simon is a trainer and runs a series of basic and advanced courses in Bio-Pharma Business Development, Biotech Deal Negotiating and Bio-entrepreneurship in Europe, North America, Russia/CIS, Latin America, Middle East and Asia.

Organisations that will benefit:

  • Pharmaceutical Companies
  • Biotech Companies
  • Suppliers
  • Law Firms
  • Banks & Investors
  • Private Equity & Hedge Funds
  • Insurance companies
  • Consultants

Who will attend:

  • C-Level Executives
  • M&A Managers
  • Business Development Managers
  • Licensing Managers
  • Valuation & Deal Closure
  • General Managers

book today for just £2,860 and save
£635 before 23rd August

Course Agenda

Day 1: Valuation Concepts ⇓

  • Fundamental Value and Relative Value
  • Valuation methodologies: Discounted Cash Flow (DCF), Net Present Value (NPV), Return on Investment (RoI), Comparables and Benchmarking
  • Top down approach vs. the sum of the parts methodology
  • Key assumptions
  • Weighted Average Cost of Capital (WACC) and discount rate
  • Practical exercise: Delegates will apply the techniques learnt to build their own valuation model for a medical product and consider different scenarios.
  • Risk assessment and the probability of achieving expected outcome, risk-adjusted NPV (rNPV)
  • Practical exercise: Delegates will create a product valuation model to determine the risk-adjusted NPV for a development stage pharmaceutical product.
  • How to value what happens beyond the model term: Terminal Value
  • An introduction to the different approaches to company valuation: Equity value and Enterprise Value

Day 2: MARKET MODELING AND VALUATION OF LICENSES ⇓

  • Workshop: Creation of a valuation model
  • Presentations: Delegates to feedback approaches adopted, assumptions made and conclusions reached
  • Interpreting the outputs from modelling
  • Key value drivers: financial, operational
  • Sensitivity analysis
  • Scenario modelling
  • How value can differ between buyers and sellers
  • Valuing developmental projects
  • Risk adjustment by stage of development
  • Decision tree analysis
  • Portfolio analysis

Day 3: Company Valuations ⇓

  • Company valuations
  • Acquisitions
  • Case Study: An insider’s view of a recent acquisition deal between two companies
  • Merger/Acquisition exercise//
  • Wrap

For further information please call: +44 (0)207 092 1045

download full agenda

The earlier you book, the more you save…

Additionally, VAT may be applicable depending on course location.
Before 23 Aug 2019Before 4 Oct 2019Before 25 Oct 2019After 25 Oct 2019
£2,860
Save £635
£3,180
Save £320
£3,340
Save £160
£3,500

  • “The depth and knowledge of my trainer was extremely impressive. In 3 days I have had, without a doubt, a masterclass on the industry. Truly world class.”

    - Gordon Dowall Potter, Past Delegate

  • “Well worth 3 days of study!”

    - Syed Hamza, Past Delegate

  • “The training was excellent! I give it a 10 and will get my trainer's support for my next challenges.”

    - Head of Partnerships & Customer Loyalty at Avis Budget, Past Delegate

  • “Extremely constructive course with a very good dynamic and passionate trainer.”

    - Managing Director at BNP Paribas, Past Delegate

  • “Impressive and cooperative trainer who wanted to make sure the delegates understood.”

    - Budgeting, Planning & Reporting Manager, Past Delegate

IN-HOUSE

We can come to you too! If you have a team of six or more, why not hold a private course? Our experts come to you and the course is tailored to your requirements.

Call +44 (0)20 7092 1045 (United Kingdom)
or emma-jane.dinan@terrapinn.com (Asia Pacific)
for more details

FIND OUT MORE

Sign up for our Monthly Course Calendars

Get Updates

© terrapinn holdings ltd mmxviii all rights reserved